Skip to main content

Peer Review reports

From: Trastuzumab and fulvestrant combination therapy for women with advanced breast cancer positive for hormone receptor and human epidermal growth factor receptor 2: a retrospective single-center study

Original Submission
15 Feb 2021 Submitted Original manuscript
26 Feb 2021 Author responded Author comments - Yukinori Ozaki
Resubmission - Version 2
26 Feb 2021 Submitted Manuscript version 2
Resubmission - Version 3
Submitted Manuscript version 3
Resubmission - Version 4
Submitted Manuscript version 4
19 Mar 2021 Reviewed Reviewer Report - Hans-christian Kolberg
3 Dec 2021 Reviewed Reviewer Report
8 Dec 2021 Author responded Author comments - Yukinori Ozaki
Resubmission - Version 5
8 Dec 2021 Submitted Manuscript version 5
Publishing
16 Dec 2021 Editorially accepted
4 Jan 2022 Article published 10.1186/s12885-021-09128-1

You can find further information about peer review here.

Back to article page